Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells

Published:1999-08 Issue:33 Volume:18 Page:4756-4766
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Reardon Dean B,Contessa Joseph N,Mikkelsen Ross B,Valerie Kristoffer,Amir Cyrus,Dent Paul,Schmidt-Ullrich Rupert K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1202849.pdf

Reference66 articles.

1. Antonyak MA, Moscatello DK and Wong AJ. . 1998 J. Biol. Chem. 273: 2817–2822.

2. Auer K, Contessa J, Brenz-Verca S, Pirola L, Rusconi S, Cooper G, Abo A, Wymann M, Davis RJ, Birrer M and Dent P. . 1998 Mol. Biol. Cell 9: 561–573.

3. Balaban N, Moni J, Shannon M, Dang L, Murphy E and Goldkorn T. . 1996 Biochim. Biophys. Acta 1314: 147–156.

4. Bentzen SM and Thames HD. . 1991 Radiother. Oncol. 22: 161–166.

5. Boulton TG, Yancopoulos GD, Gregory JS, Slaughter C, Moomaw C, Hsu J and Cobb MH. . 1990 Science 249: 64–67.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in Radiosensitivity According to EGFR Mutation Status in Non-Small Cell Lung Cancer: A Clinical and In Vitro Study;Journal of Personalized Medicine;2023-12-25

2. Gemcitabine resistance in non‐small cell lung cancer is mediated through activation of the PI3K/AKT/NF‐κB pathway and suppression of ERK signaling by reactive oxygen species;Journal of Biochemical and Molecular Toxicology;2023-08-11

3. Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma;Frontiers in Genetics;2022-08-12

4. Targeting PI3K/Akt signal transduction for cancer therapy;Signal Transduction and Targeted Therapy;2021-12

5. Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub‐analysis of the ProfiLER protocol;Head & Neck;2021-10-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3